Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$869K Sell
850
-61
-7% -$58.6K 0.12% 124
2024
Q1
$884K Hold
911
0.12% 130
2023
Q4
$690K Hold
911
0.1% 137
2023
Q3
$536K Buy
911
+1
+0.1% +$664 0.09% 145
2023
Q2
$660K Buy
910
+225
+33% +$153K 0.1% 141
2023
Q1
$466K Hold
685
0.08% 159
2022
Q4
$374K Hold
685
0.07% 173
2022
Q3
$285K Hold
685
0.05% 187
2022
Q2
$326K Hold
685
0.05% 186
2022
Q1
$458K Hold
685
0.06% 168
2021
Q4
$545K Buy
685
+150
+28% +$119K 0.07% 164
2021
Q3
$399K Hold
535
0.06% 179
2021
Q2
$370K Hold
535
0.06% 187
2021
Q1
$330K Buy
535
+65
+14% +$36K 0.05% 181
2020
Q4
$229K Buy
+470
New +$198K 0.04% 200

Other funds holding ASML

Abbrea Capital's ASML Position: Q2 2024 in Review

Abbrea Capital reduced its ASML (ASML) stake by 6.7% in Q2 2024, selling an estimated $58.6K and leaving 850 shares worth $869K. The position accounts for 0.12% of the portfolio, ranked #124.

Abbrea Capital first reported a position in ASML in Q4 2020 and has held it in 15 quarters since. The position peaked at $884K in Q1 2024. 1,599 funds tracked by Wall St. Rank hold ASML as of Q2 2024.

  • Abbrea Capital held 850 shares of ASML worth $869K as of Q2 2024.
  • Abbrea Capital sold 61 ASML shares in Q2 2024, an estimated $58.6K.
  • ASML made up 0.12% of Abbrea Capital's portfolio in Q2 2024, its #124 holding.
  • Abbrea Capital first reported a position in ASML in Q4 2020 and has held it in 15 quarters since.
  • Abbrea Capital's ASML position peaked at $884K in Q1 2024.
  • 1,599 funds tracked by Wall St. Rank held ASML as of Q2 2024.

Based on Abbrea Capital's 13F filing for Q2 2024, filed 8 Aug 2024.